创伤质量改进计划中心体外膜氧合的使用:时间趋势与未来方向
该研究基于美国外科医师学会创伤质量改进计划数据集,纳入2012至2016年入住Ⅰ级或Ⅱ级创伤中心、至少接受1天机械通气的194,314例严重创伤成人,其中269例(0.14%)接受ECMO。ECMO患者死亡率显著高于非ECMO患者(32% vs. 19%)。2012至2016年ECMO标准化率从75.2例/10万显著升至179.0例/10万,年均增长率24%。450个中心中82个(18%)报告至少1例ECMO创伤病例,其中34个(41%)仅报告1例。作者认为ECMO可能是创伤相关呼吸或心肺衰竭的潜在治疗策略,但鉴于操作罕见,有必要制定适应证和实践指南。
要点
- 194,314例接受机械通气的严重创伤成人中269例(0.14%)使用ECMO,ECMO患者死亡率32% vs. 非ECMO患者19%。
- 2012至2016年ECMO标准化率从75.2升至179.0例/10万严重创伤机械通气患者,年均增长率24%。
- 450个中心中仅82个(18%)报告至少1例ECMO创伤病例,其中34个(41%)仅报告1例。
- 接受ECMO的创伤患者中三分之二存活出院。
- 作者认为ECMO可能是创伤相关呼吸或心肺衰竭的潜在治疗策略,但有必要制定适应证和实践指南。
适用人群与场景
- 2012至2016年入住Ⅰ级或Ⅱ级创伤中心、至少有一处严重损伤、接受至少1天机械通气的成人创伤患者。
研究设计与关键结果
- 研究类型为基于美国外科医师学会创伤质量改进计划数据集的队列分析,纳入194,314例接受机械通气的严重创伤成人,覆盖450个中心。
- 269例(0.14%)在住院期间接受ECMO;ECMO患者死亡率显著高于非ECMO患者(32% vs. 19%)。
- 2012至2016年ECMO标准化率从75.2例/10万显著升至179.0例/10万严重创伤机械通气患者,年均增长率24%。
- 450个中心中82个(18%)报告至少1例ECMO创伤病例,其中34个(41%)仅报告1例。
- 接受ECMO的创伤患者中三分之二存活出院。
证据类型、等级与局限
- 证据类型:基于创伤质量改进计划数据集的队列分析;证据等级:治疗/临床管理,level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为ECMO可能是创伤相关呼吸或心肺衰竭的潜在治疗策略。
- 作者认为鉴于ECMO操作罕见,有必要制定关于创伤中ECMO适应证和实施方法的实践指南。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Increased clinical experience and the decreased need for systemic anticoagulation have renewed interest in the use of extracorporeal membrane oxygenation (ECMO) for posttraumatic respiratory and cardiopulmonary failure. The objectives of this study were to describe the incidence and temporal trends of ECMO use at trauma centers, the outcomes of trauma patients undergoing ECMO, and the characteristics of trauma centers providing ECMO.
METHODS: Data were derived from the American College of Surgeons Trauma Quality Improvement Program data set. We included adults with at least one severe injury admitted to a level I or II trauma center between 2012 and 2016 who received at least 1 day of mechanical ventilation. Patients were categorized based on whether or not they received ECMO during their admission. The primary outcome was change in the incidence of ECMO across study years. We also evaluated patient outcomes and variation in ECMO volumes across centers.
RESULTS: Of 194,314 severely injured patients undergoing mechanical ventilation across 450 centers, 269 (0.14%) received ECMO. Extracorporeal membrane oxygenation patients had significantly higher mortality than non-ECMO patients (32% vs. 19%). The standardized rate of ECMO from 2012 to 2016 increased significantly from 75.2 to 179.0 cases per 100,000 severely injured patients undergoing mechanical ventilation. The average annual growth rate was 24%. Of the 82 centers(18%) reporting at least 1 ECMO trauma case, 34 (41%) reported only a single case.
CONCLUSION: The use of ECMO for trauma, although rare, is rapidly increasing. Two thirds of patients who receive ECMO following traumatic injury survive their hospitalization. These data suggest that ECMO represents a potential treatment strategy for trauma patients with respiratory or cardiopulmonary failure. However, given the rarity of the procedure, there exists an opportunity to develop practice guidelines regarding the indications for, and approach to, ECMO in the setting of trauma.
LEVEL OF EVIDENCE: Therapeutic/care management, level IV.
参考来源
- Guttman MP, Tillmann BW, Pannell D, et al. Extracorporeal membrane oxygenation use in Trauma Quality Improvement Program centers: Temporal trends and future directions. J Trauma Acute Care Surg. 2020. PMID: 32744831. doi:10.1097/TA.0000000000002756
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。